Platelets prevent acute hepatitis induced by anti-fas antibody

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 2, 2011, Pages 348-355

  Hisakura, Katsuji ^a   Murata, Soichiro ^a   Takahashi, Kazuhiro ^a   Matsuo, Ryota ^a   Pak, Sugiru ^a   Ikeda, Naoya ^a   Kawasaki, Takuya ^a   Kohno, Keisuke ^a   Myronovych, Andriy ^a   Nakano, Yoritaka ^a   Ikeda, Osamu ^a   Watanabe, Motonobu ^a   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Acute hepatitis; Apoptosis; Hepatocyte; Platelets

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; FAS ANTIBODY; PROTEIN BCL XL; PROTEIN KINASE B; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; STAUROSPORINE; THROMBOPOIETIN;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTOSIS;

EID: 78851472342     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06334.x     Document Type: Article

References (50)

1. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culture. Proc. Natl. Acad. Sci. USA 1986; 83: 6489-93.
2. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987; 224: 311-16.
3. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-b in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. chem. 1983; 258: 7155-60.
4. Oka Y, Orth DN. Human plasma epidermal growth factor/b-urogastrone is associated with blood platelets. J. Clin. Invest. 1983; 72: 249-59.
5. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic, and delayed healing. Front. Biosci. 2004; 9: 283-9.
6. Gruber R, Baron M, Busenlechner D, Kandler B, Fuerst G, Watzek G. Proliferation and osteogenic differentiation of cells from cortical bone cylinders, bone particles from mill, and drilling dust. J. Oral Maxillofac. Surg. 2005; 63: 238-43.
7. Gerard D, Carlson ER, Gotcher JE, Jacobs M. Effects of platelet-rich plasma on the healing of autologous bone grafted mandibular defects in dogs. J. Oral Maxillofac. Surg. 2006; 64: 443-51.
8. Nocito A, Georgiev P, Dahm F etal. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007; 45: 369-76.
9. Murata S, Ohkohchi N, Matsuo R, Ikeda O, Myronovych A, Hoshi R. Platelets promote liver regeneration in early period after hepatectomy in mice. World J. Surg. 2007; 31: 808-16.
10. Matsuo R, Ohkohchi N, Murata S etal. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J. Surg. Res. 2008; 145: 279-86.
11. Myronovych A, Murata S, Chiba M etal. Role of platelets on liver regeneration after 90% hepatectomy in mice. J. Hepatol. 2008; 49: 363-72.
12. Murata S, Hashimoto I, Nakano Y, Myronovych A, Watanabe M, Ohkohchi N. Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann. Surg. 2008; 248: 821-8.
13. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
14. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-57.
15. Pinkoski MJ, Brunner T, Green DR, Lin T. Fas and Fas ligand in gut and liver. Am. J. Physiol. 2000; 278: G354-66.
16. Ogasawara J, Watanabe-Fukunaga R, Adachi M etal. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-9.
17. Kanzler S, Galle PR. Apoptosis and the liver. Semin. Cancer Biol. 2000; 10: 173-84.
18. Medema JP, Scaffidi C, Krammer PH, Peter ME. Bcl-xL act downstream of Caspase-8 activation by the CD95 death-inducing signaling complex. J. Biol. Chem. 1998; 273: 3388-93.
19. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J. Biol. Chem. 2001; 276: 26605-13.
20. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptosis program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.
21. Yang J, Liu X, Bhalla K etal. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
22. Wei MC, Zong WX, Cheng EH etal. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-30.
23. Feng G, Kaplowitz N. Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. J. Clin. Invest. 2000; 105: 329-39.
24. Shibuya K, Akahori H, Takahashi K, Tahara E, Kato T, Miyazaki H. Multilineage hematopoietic recovery by single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice. Blood 1998; 91: 37-45.
25. Wu JC, Merlino G, Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc. Natl. Acad. Sci. USA 1994; 91: 674-8.
26. Masuura T, Kawada M, Hasumura S etal. High density culture of immortalized liver endothelial cells in the radial-floww bioreactor in the development of an artificial liver. Int. J. Artif. Organs 1998; 21: 229-34.
27. Mochizuki K, Hayashi N, Hiramatsu N etal. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J. Hepatol. 1996; 24: 1-7.
28. Mita E, Hayashi N, Ito S etal. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem. Biophys. Res. Commun. 1994; 204: 468-74.
29. Wanner GA, Mica L, Wanner-schmid E etal. Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J. 1999; 13: 1239-48.
30. Endo Y, Nakamura M. The effect of lipopolysaccharide, interleukin-1 and tumor necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br. J. Pharmacol. 1992; 105: 613-19.
31. Endo Y, Nakamura M. Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen. Pharmacol. 1993; 24: 1039-53.
32. Nakamura M, Shibazaki M, Nitta Y, Endo Y. Translocation of platelets into Disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1, and tumor necrosis factor: the role of Kupffer cells. J. Hepatol. 1998; 28: 991-9.
33. Nakano Y, Kondo T, Matsuo R etal. Platelet dynamics in the early phase of postischemic liver in vivo. J. Surg. Res. 2008; 149: 192-8.
34. Datta SR, Dudek H, Xu T etal. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-41.
35. Dudek H, Datta SR, Franke TF etal. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-5.
36. Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 2003; 10: 508-15.
37. Edwards MJ, Keller BJ, Kauffman FC, Thuman RG. The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol. Appl. Pharmacol. 1993; 119: 275-9.
38. Planaguma A, Claria J, Miquel R etal. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J. 2005; 19: 1120-2.
39. Schulze-Bergkamen H, Brenner D, Krueger A etal. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 2004; 39: 645-54.
40. Seya K, Ohkohchi N, Mori S. Changes in the ability of ATP synthesis in the mitochondrial membrane in the rat liver injured by carbon tetrachloride. Tohoku J. Exp. Med. 1996; 178: 425-30.
41. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419-31.
42. Kaushansky K, Broudy VC, Lin N etal. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc. Natl. Acad. Sci. USA 1995; 92: 3234-38.
43. Kirito K, Watanabe T, Sawada K, Endo H, Ozawa K, Komatsu N. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways. J. Biol. Chem. 2002; 277: 8329-37.
44. Cardier JE, Dempsey J. Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells. Blood 1998; 91: 923-9.
45. Cardier JE. Effects of megakaryocyte growth and development factor (thrombopoietin) on liver endothelial cells in vitro. Microvasc. Res. 1999; 58: 108-13.
46. Ping C, Xiaoling D, Jin Z, Jiahong D, Jiming D, Lin Z. Hepatic sinusoidal endothelial cells promote hepatocyte proliferation early after partial hepatectomy in rats. Arch. Med. Res. 2006; 37: 576-83.
47. Janin A, Deschaumes C, Daneshpouy M etal. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood 2002; 99: 2940-7.
48. Ju C, Reilly TP, Bourdi M etal. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem. Res. Toxicol. 2002; 15: 1504-13.
49. Zhang W, Chen XP, Zhang WG etal. Hepatic non-parenchymal cells and extracellular matrix participate in oval cell-mediated liver regeneration. World J. Gastroenterol. 2009; 15: 552-60.
50. Tanaka Y, Sohda T, Matsuo K etal. Vascular endothelial growth factor reduces Fas-mediated acute liver injury in mice. J. Gastroenterol. Hepatol. 2008; 23: 207-11.